Healthcare >> Analyst Interviews >> April 6, 2009
Matt Dolan is the Senior Medical Device Research Analyst at ROTH Capital
Partners, LLC, and has been covering the industry at the firm for over five
years. His coverage universe is highlighted by 20 small cap medical device
companies. Prior to joining ROTH, he worked as an analyst at a merchant bank /
hedge fund in New York, specializing in micro and small cap medical device,
biotechnology and pharmaceutical companies. He received his Bachelor's degree in
Economics/Pre-Med from Northwestern University. Profile
companies?
Mr. Dolan: In general, the industry is beginning to contemplate the implications
of Obama's new budget
